Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease

F. Yu Kopylov; Копылов Филипп Юрьевич; Yu. M Nikitina; Никитина Ю. М; E. A Makukh; Макух Е. А; A. L Syrkin; Сыркин Абрам Львович

doi:10.26442/CS44966

Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease

作者: Kopylov F.¹, Nikitina Y.¹, Makukh E.¹, Syrkin A.¹
隶属关系:
1. Первый Московский государственный медицинский университет им. И.М.Сеченова
期: 卷 1, 编号 1 (2010)
页面: 57-61
栏目: Articles
URL: https://journals.rcsi.science/2221-7185/article/view/44966
DOI: https://doi.org/10.26442/CS44966
ID: 44966

如何引用文章

全文:

详细
全文:
作者简介
参考
统计

详细

A trial was carried out to study the efficiency and safety of therapy with the new antiasthenic drug Ladasten. The findings suggest its high safety and efficiency and good tolerability of Ladasten in the treatment of asthenia and asthenic spectrum disorders, the development of which is associated with cardiovascular disease.